Help us make Medscape the best clinical resource possible. Please use this form to submit your questions or comments on how to make this resource center more useful to clinicians.
People with ulcerative proctitis, a milder and more limited form of ulcerative colitis, are not at higher risk of developing rectal cancer than the general population. This is shown in a new Swedish ...
More than a quarter of patients with ulcerative colitis do not receive prior advanced therapy before initiating mirikizumab, according to real-world data presented at Crohn’s & Colitis ...
Your belly hurts. The diarrhea keeps coming. And you certainly don’t feel like eating. These are telltale signs of colitis. But which kind? Colitis is a term used to describe inflammation in your ...
A new study indicates a common genetic variant may interact with gut bacteria to trigger chronic inflammation in ulcerative colitis. The findings may help explain why people experience the disease ...
Irritable bowel syndrome and ulcerative colitis are chronic conditions that affect the digestive tract. These conditions may have similar symptoms, but there are important differences in how they’re ...
Mesalamine is a medicine for ulcerative colitis (UC) and other types of inflammatory bowel disease (IBD). It belongs to a group of anti-inflammatory medicines called aminosalicylates or ...
People with ulcerative proctitis, a milder and more limited form of ulcerative colitis, are not at higher risk of developing rectal cancer than the general population. This is shown in a new Swedish ...
Colitis and ulcerative colitis (UC) can look very similar because they share symptoms like abdominal pain, diarrhea, and bloody stool, and they both involve inflammation of the colon (the large ...